Showing results (171-180 of 251) with videos related to

Sort By:
Pageof 26
Anti-Cancer Drugs|October 1, 1995
Activity of N-benzyl-adriamycin-14-valerate (AD198), a new anthracycline derivate, in multidrug resistant human ovarian and breast carcinoma cell linesA Harstrick, U Vanhoefer, N Schleucher, et al.
Experimental Hematology|November 10, 1998
In acute myeloid leukemia, coexpression of at least two proteins, including P-glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat-shock protein 27, is predictive of the response to induction chemotherapyS Kasimir-Bauer, H Ottinger, P Meusers, et al.
Clinical Immunology and Immunopathology|October 1, 1992
Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disordersU B Wandl, M Nagel-Hiemke, D May, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1992
Treatment of high-risk, nonseminomatous testicular cancer with cisplatin, ifosfamide and bleomycin: long-term resultsU B Wandl, K Günzel, R Kath, et al.
Journal of Cancer Research and Clinical Oncology|August 10, 2000
Type and position of promoter elements in retroviral vectors have substantial effects on the expression level of an enhanced green fluorescent protein reporter geneM Flasshove, W Bardenheuer, A Schneider, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Etoposide, folinic acid, and 5-fluorouracil in carboplatin-pretreated patients with advanced gastric cancerH Wilke, P Preusser, M Stahl, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|January 1, 1994
[Surgery of locally advanced non-small-cell bronchial cancer after intensive preoperative chemo-/radiotherapy]G Stamatis, H Wilke, W Eberhardt, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1990
[DL-1,2-bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancerR Müller, R Gust, G Bernhardt, et al.
Oncology (Williston Park, N.Y.)|April 1, 1997
Infusional 5-FU, folinic acid, paclitaxel, and cisplatin for metastatic breast cancerU Klaassen, H Wilke, C Müller, et al.
Bone Marrow Transplantation|November 18, 2000
Transplantation of highly purified HLA-identical sibling donor peripheral blood CD34+ cells without prophylactic post-transplant immunosuppression in adult patients with first chronic phase chronic myeloid leukemia: results of a phase II studyD W Beelen, R Peceny, A Elmaagacli, et al.
Pageof 26